Gastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-up

Basit Öğe Kaydı
dc.contributor.authorYalcin, Suayib
dc.contributor.authorBayram, Fahri
dc.contributor.authorErdamar, Sibel
dc.contributor.authorKucuk, Oztem
dc.contributor.authorOruc, Nevin
dc.contributor.authorCoker, Ahmet
dc.date.accessioned2019-10-27T11:10:07Z
dc.date.available2019-10-27T11:10:07Z
dc.date.issued2017
dc.departmentEge Üniversitesien_US
dc.description.abstractGastroenteropancreatic neuroendocrine tumors (GEPNETs) are a relatively rare, heterogeneous group of diseases in which important advances have been observed in the diagnosis and treatment as well as in our understanding of the biology and genetics of the disease in recent years. Given the insufficient scientific data available on evidence-based management of GEPNETs and the differences in circumstances in individual countries, a multidisciplinary study group was established to provide guidelines for the management of GEPNETS. This study group consisted of a medical oncologist, endocrinologist, surgeon, pathologist, gastroenterologist, and a nuclear medicine specialist, who aimed to prepare a practical guide in the light of existing scientific data and international guidelines, to be used in common clinical practice.en_US
dc.description.sponsorshipRocheRoche Holding; PfizerPfizer; Celgeneen_US
dc.description.sponsorshipSuayib Yalcin has had advisory board role in Novartis, Roche, Pfizer, Amgen and speaker Bureau role for Gen ilac, Novartis, Roche, Pfizer and travel grant from Roche and Pfizer, and research grant from Celgene.en_US
dc.identifier.doi10.5114/aoms.2017.65449en_US
dc.identifier.endpage282en_US
dc.identifier.issn1734-1922
dc.identifier.issn1896-9151
dc.identifier.issue2en_US
dc.identifier.pmid28261279en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage271en_US
dc.identifier.urihttps://doi.org/10.5114/aoms.2017.65449
dc.identifier.urihttps://hdl.handle.net/11454/32361
dc.identifier.volume13en_US
dc.identifier.wosWOS:000395365500001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.ispartofArchives of Medical Scienceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectneuroendocrine tumoren_US
dc.subjectguidelineen_US
dc.subjectconsensusen_US
dc.subjectdiagnosisen_US
dc.subjecttreatmenten_US
dc.titleGastroenteropancreatic neuroendocrine tumors: recommendations of Turkish multidisciplinary neuroendocrine tumor study group on diagnosis, treatment and follow-upen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu